PanGen Biotech Revenue

In the year 2025, PanGen Biotech had annual revenue of 13.42B KRW, down -8.56%. PanGen Biotech had revenue of 2.48B in the quarter ending December 31, 2025, a decrease of -42.86%.

Revenue

13.42B

Revenue Growth

-8.56%

P/S Ratio

6.04

Revenue / Employee

n/a

Employees

n/a

Market Cap

81.10B

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	13.42B	-1.26B	-8.56%
Dec 31, 2024	14.67B	7.36B	100.58%
Dec 31, 2023	7.32B	814.47M	12.53%
Dec 31, 2022	6.50B	-1.43B	-18.08%
Dec 31, 2021	7.94B	1.74B	28.18%
Dec 31, 2020	Pro	Pro	Pro
Dec 31, 2019	Pro	Pro	Pro
Dec 31, 2018	Pro	Pro	Pro
Dec 31, 2017	Pro	Pro	Pro
Dec 31, 2016	Pro	Pro	Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
Progen	450.00M
Naturalendo Tech	22.23B
IMGT Co.,Ltd.	102.33M
Shaperon	227.80M
Quratis	2.46B
Choong Ang Vaccine Laboratory	39.19B
CTCBIO	123.77B
Psomagen	59.19B

Revenue Rankings